At CPhI (Frankfurt November 1-3, 2022), Telstar will be promoting a new Pharma 4.0 IoT Data platform for predictive and preventive maintenance. Under the “Insights” brand, it is a non-intrusive cloud platform that collects and analyses in real time the data of the equipment in operation, allowing for the generation of a customized specific predictive & preventive maintenance plan.
Telstar Insights runs simultaneously data collection, processing and analysis, comparing assets of the same type in similar production condition, even from different sources, using analytical and big data tools through a multi-tenant Internet of Things (IoT) platform. In this way, the multiuser platform Insights can analyse a substantial quantity of aggregated information & functional data, allowing the users to increase the level of knowledge on their own equipment, benchmarking the behaviour of other similar equipment in operation in the market. At the end, the user can obtain reliable and accurate information and generate a prediction plan. This particular Insights feature provides the ability to generate and, at the same time, manage comparative indicators to improve overall equipment efficiency (OEE) and move towards predictive maintenance.
Based on specialized partner “shared” model and SaaS (Software as a Service), Insights is conceived to improve productivity and maximize assets performance throughout their lifecycle.
Smart Format shortlisted for the CPhI Pharma Awards 2022
At CPhI, the company will also be promoting new developments in both in line management devices and process analytical technology for pharmaceutical freeze-drying systems:
Endorsing Pharma industry with more innovative developments
At CPhI, Telstar’s portfolio will also be strengthened with innovative solutions in isolation technology, sterilization applications, and advanced aseptic processes integrated systems & services.
Furthermore, turnkey engineering & construction services for process facilities will also be present at this event. They are the next generation of engineering services for pharmaceutical production, designed to offer greater performance with less environmental impact from the initial design. In this context, Telstar DiSQ will also be promoted at CPhI, a new Digital Smart Qualification software for commissioning and qualification with digital documents to optimize the development lifecycle, risk management, validation, and verification processes.
Telstar is a leading global brand of aseptic process solutions. The company, part of the azbil Group, specializes in the development of highly complex projects, from integrated process equipment to design, engineering and construction of complete turnkey pharmaceutical and biotech production facilities, critical installations, clean rooms, and R&D laboratories.
Telstar at CpHI 2022 – Stand 60C51